{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:45:25Z","timestamp":1792604725219,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Mucor within the airways of immunocompromised patients often signifies an invasive life-threatening infection. However, its significance in immunocompetent patients with chronic lung diseases is less clear. We aimed to assess the clinical implication of mucor in airway-secretion cultures of these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A single-center retrospective cohort study was performed. Patients with cystic fibrosis (CF), primary ciliary dyskinesia (PCD) or non-CF\/non-PCD bronchiectasis followed in our Pediatric Pulmonary Institute, with sputum or bronchoalveolar lavage cultures growing Mucorales molds in the years 2010\u20132022, were included. Demographic and clinical parameters such as body mass index and spirometry values (forced expiratory volume at 1 second) were collected and compared with values up to 12 months prior to and following the index (positive culture) visit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 27 patients of whom 22 (82%) patients were with CF, 3 with PCD (11%) and 2 (7%) with non-CF\/non-PCD bronchiectasis were included. Median age was 21.8 (14.9\u201332.1) years, with forced expiratory volume at 1 second of 62.8% \u00b1 21.9% at the index visit. None of the patients developed disseminated disease, none had clinical or radiological evidence of fungal disease and none required antifungal therapy. Throughout the 12 months prior to and following the positive cultures, no significant changes were noted in body mass index, forced expiratory volume at 1 second, frequency of pulmonary exacerbations, days of hospitalization or days of antibiotic treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Evidence of mucor in airway cultures of immunocompetent patients with chronic lung disease does not necessarily signify clinical deterioration nor suggests invasive fungal disease. Larger, long-term prospective studies are required to obviate the need for a thorough evaluation in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004427","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:00:12Z","timestamp":1718218812000},"page":"987-990","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Significance of Mucor in Airway Culture of Immunocompetent Patients With Chronic Lung Disease"],"prefix":"10.1097","volume":"43","author":[{"given":"Suha","family":"Rizik","sequence":"first","affiliation":[{"name":"From the Pediatric Pulmonary Institute and CF Center, Rappaport Children\u2019s Hospital, Rambam Health Care Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Bentur","sequence":"additional","affiliation":[{"name":"From the Pediatric Pulmonary Institute and CF Center, Rappaport Children\u2019s Hospital, Rambam Health Care Campus"},{"name":"Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Bar-Yoseph","sequence":"additional","affiliation":[{"name":"From the Pediatric Pulmonary Institute and CF Center, Rappaport Children\u2019s Hospital, Rambam Health Care Campus"},{"name":"Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Szwarcwort","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Rambam Health Care Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Pollak","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Rambam Health Care Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gur","sequence":"additional","affiliation":[{"name":"From the Pediatric Pulmonary Institute and CF Center, Rappaport Children\u2019s Hospital, Rambam Health Care Campus"},{"name":"Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9979-6552","authenticated-orcid":false,"given":"Michal","family":"Meir","sequence":"additional","affiliation":[{"name":"Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology"},{"name":"Pediatric Infectious Diseases Unit, Rappaport Children\u2019s Hospital, Rambam Health Care Campus, Haifa, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis.","volume":"35","author":"Steinbrink","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jpids\/piz007","article-title":"Pediatric mucormycosis: a 10-year systematic review of reported cases and review of the literature.","volume":"8","author":"Otto","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis.","volume":"41","author":"Reid","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0970-2113.125991","article-title":"Solitary pulmonary nodule: a rare presentation of pulmonary mucormycosis in an immunocompetent adult.","volume":"31","author":"Sarkar","year":"2014","journal-title":"Lung India"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11046-016-9999-1","article-title":"Pulmonary fungal diseases in immunocompetent hosts: a single-center retrospective analysis of 35 subjects.","volume":"181","author":"Yan","year":"2016","journal-title":"Mycopathologia"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-021-01504-8","article-title":"Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature.","volume":"21","author":"He","year":"2021","journal-title":"BMC Pulm Med"},{"key":"R9-20250614","first-page":"107","article-title":"Pulmonary mucoraceous fungal ball.","volume":"43","author":"Lahiri","year":"2001","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1542\/pir.35.5.194","article-title":"Cystic fibrosis.","volume":"35","author":"Paranjape","year":"2014","journal-title":"Pediatr Rev"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/pathogens10050618","article-title":"Fungal infection and inflammation in cystic fibrosis.","volume":"10","author":"Poore","year":"2021","journal-title":"Pathogens"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"bcr2013201360","DOI":"10.1136\/bcr-2013-201360","article-title":"Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.","volume":"10","author":"Mosquera","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.transproceed.2014.05.033","article-title":"Fungal infection by Mucorales order in lung transplantation: 4 case reports.","volume":"46","author":"Neto","year":"2014","journal-title":"Transplant Proc"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: an update.","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcf.2017.03.011","article-title":"CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.","volume":"16","author":"Tarique","year":"2017","journal-title":"J Cyst Fibros"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1164\/rccm.201509-1811ED","article-title":"Macrophage dysfunction in cystic fibrosis: a therapeutic target to enhance self-immunity.","volume":"192","author":"Bonfield","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/ijms22041952","article-title":"Dysfunctional inflammation in cystic fibrosis airways: from mechanisms to novel therapeutic approaches.","volume":"22","author":"Ghigo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/INF.0b013e3181f63c90","article-title":"Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature.","volume":"30","author":"Massam","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1099-0496(199902)27:2<130::AID-PPUL10>3.0.CO;2-1","article-title":"Fatal invasive aspergillosis in an adolescent with cystic fibrosis.","volume":"27","author":"Brown","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-017-0182-0","article-title":"Progress in definition, prevention and treatment of fungal infections in cystic fibrosis.","volume":"183","author":"Schwarz","year":"2018","journal-title":"Mycopathologia"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.2005.047332","article-title":"Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.","volume":"61","author":"Twiss","year":"2006","journal-title":"Thorax"},{"key":"R22-20250614","first-page":"55","article-title":"A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis.","volume":"20","author":"Harun","year":"2016","journal-title":"Paediatr Respir Rev"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"2101918","DOI":"10.1183\/13993003.01918-2021","article-title":"Lung function from school age to adulthood in primary ciliary dyskinesia.","volume":"60","author":"Halbeisen","year":"2022","journal-title":"Eur Respir J"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update.","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/j.ijid.2011.02.005","article-title":"Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature.","volume":"15","author":"Mignogna","year":"2011","journal-title":"Int J Infect Dis"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/myc.13123","article-title":"Mucormycosis in the Middle East and North Africa: analysis of the FungiScope\u00ae registry and cases from the literature.","volume":"63","author":"Stemler","year":"2020","journal-title":"Mycoses"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:06:27Z","timestamp":1749942387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004427","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}